Bibliographic record
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2…
Rosenstock J, Wysham C, Frías JP, Kaneko S, Lee CJ, Fernández Landó L, Mao H, Cui X, Karanikas CA, Thieu VT. The Lancet 2021
§1Bibliographic record
§1.1Record
- Authors
- Rosenstock J, Wysham C, Frías JP, Kaneko S, Lee CJ, Fernández Landó L, Mao H, Cui X, Karanikas CA, Thieu VT
- Title
- Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
- Source
- The Lancet
- Year
- 2021
- Volume, issue, pages
- 398(10295):143–155
- Digital object identifier
- 10.1016/S0140-6736(21)01324-6
- PubMed identifier
- 34186022
- Record type
- Journal article
- Institute identifier
- CEI-BR-092
§1.2Institute documents citing this record
Table 1. Documents in the Institute set that cite this record.
| Document | Series |
|---|---|
| Monograph: Tirzepatide | Compound monograph |
| 1 citing document. | |
§1.3Subject tags
tirzepatide t2dm SURPASS
Compound Evidence Institute · CEI-BR-092 · https://compoundevidence.com/bibliography/rosenstock2021/ · retrieved 30 July 2026